CSat Investment Advisory’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$46K Buy
439
+103
+31% +$10.4K 0.04% 216
2020
Q4
$34K Sell
336
-6,799
-95% -$639K 0.03% 240
2020
Q3
$600K Buy
7,135
+1,686
+31% +$131K 0.05% 167
2020
Q2
$354K Buy
5,449
+1,801
+49% +$119K 0.04% 213
2020
Q1
$237K Buy
3,648
+2,477
+212% +$195K 0.05% 214
2019
Q4
$93K Buy
1,171
+466
+66% +$36.3K 0.02% 382
2019
Q3
$56K Buy
705
+57
+9% +$4.48K 0.02% 483
2019
Q2
$54K Buy
648
+363
+127% +$28.9K 0.02% 469
2019
Q1
$23K Sell
285
-32
-10% -$2.33K 0.01% 291
2018
Q4
$21K Buy
317
+130
+70% +$8.99K 0.01% 275
2018
Q3
$15K Buy
187
+8
+4% +$597 0.01% 290
2018
Q2
$12K Buy
+179
New +$13K 0.01% 313

Other funds holding XYL

CSat Investment Advisory's XYL Position: Q1 2021 in Review

CSat Investment Advisory increased its Xylem (XYL) stake by 31% in Q1 2021, buying an estimated $10.4K and bringing the position to 439 shares worth $46K. The position accounts for 0.04% of the portfolio, ranked #216.

CSat Investment Advisory first reported a position in XYL in Q2 2018 and has held it in 12 quarters since. The position peaked at $600K in Q3 2020. 749 funds tracked by Wall St. Rank hold XYL as of Q1 2021.

  • CSat Investment Advisory held 439 shares of Xylem worth $46K as of Q1 2021.
  • CSat Investment Advisory bought 103 Xylem shares in Q1 2021, an estimated $10.4K.
  • Xylem made up 0.04% of CSat Investment Advisory's portfolio in Q1 2021, its #216 holding.
  • CSat Investment Advisory first reported a position in Xylem in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Xylem position peaked at $600K in Q3 2020.
  • 749 funds tracked by Wall St. Rank held Xylem as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.